PH12017500479A1
(en )
2017-07-31
Liquid inhalation formulation comprising prl554
EP3544724A4
(en )
2020-10-14
PARTICLES INCLUDING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND THEIR METHODS OF USE
IL255317A0
(en )
2017-12-31
Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of using them
EP3346915A4
(en )
2018-10-10
Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart
EP3686200A3
(en )
2020-09-09
Bicyclic heterocycle compounds and their uses in therapy
MX2017003819A
(es )
2017-06-15
Macrociclos peptidomimeticos y formulaciones de los mismos.
BR112012027743A2
(pt )
2017-03-14
ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas
AU2014375637A1
(en )
2016-07-14
Formula of neuregulin preparation
HRP20200662T1
(hr )
2020-10-02
Ljekoviti pripravak koji sadrži spoj diamino heterocikličkog karboksamida kao aktivni sastojak
GEP20186910B
(en )
2018-10-25
1,2-substituted cyclopentanes as orexin receptor antagonists
WO2015171558A3
(en )
2017-07-20
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
PH12018500762A1
(en )
2018-10-29
Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
MA52252A
(fr )
2021-02-17
Formulation de poudre nasale pour le traitement de l'hypoglycémie
MA39765A
(fr )
2017-02-01
Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
MY187251A
(en )
2021-09-15
[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases
MA45158A
(fr )
2019-04-10
Composition pharmaceutique comprenant de l'éteplirsen
WO2017143115A3
(en )
2017-10-05
Enhancing the therapeutic activity of an immune checkpoint inhibitor
TH174318B
(th )
2018-03-08
สูตรผสม
TH174318A
(th )
2018-03-08
สูตรผสม
EP3475442A4
(en )
2019-12-04
12 (S) -HYDROXYEICOSATRIENOIC ACID COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
EA202091618A1
(ru )
2021-03-17
Композиция кетамина в виде сухого порошка для применения при лечении депрессии ингаляционным путем
IL277933A
(en )
2020-11-30
A new crystalline salt of cysteamine for the preparation of inhalable particles
EP4082544A4
(en )
2024-01-10
AQUEOUS SUSPENSION COMPOSITION CONTAINING SIROLIMUS OR A SALT THEREOF
PH12018502195A1
(en )
2019-09-23
Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases
AR112040A1
(es )
2019-09-11
Sal de n-(2,6-dietilfenil)-8-({4-[4-(dimetilamino)piperidin-1-il]-2-metoxifenil}amino)-1-metil-4,5-dihidro-1h-pirazolo[4,3-h]quinazolina-3-carboxamida, su preparación, y las formulaciones que la contienen